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ThnrRODUCTION AND HISTORY

The alpha-hemolytic streptococcus has been

considered as the main organism in the etiology of

subacute bacterial endocarditis for many years, and

more recently it h�s been stated that it can be isolated
in about 9.5 -per cent of the cases. (57}

This state-

ment was ml.de by Dr. Emanuel Libman who has been

studying the clinical aspect of this disease for many

yeo.rs, and can rightly be called the father of subacute
bacterial endocarditis.

However, there �re many strains

of the alpha-hemolytic streptococcus, and it is only
the non-hemolytic, "green-producing" strain better -

known as the Streptococcus viridans which is of importance
in th e etiology of' subacute bacta:- ial endocarditis.

Nevertheless, there is a variance of ppinion as to the

existence of different strains or species of the StreP
tococcus viridans, and thus it is the purpose of this

paper to give a description of the various strains in

the a1pha-hemoiyt.1c group which may be responsible

for the development of subacute bacterial endocarditis,
and also their SJSOept.ibility to the v&rious forms of'
chemotherapy.

The first true recognition of the subacute :form

of endocarditis was made in 1885 by William Osler.(78}
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However, the first unmistakable clinical picture of

infectious endocarditis was described in 1852 by Kirkes
(47), and again in 1368 a case of infectious endocarditis

of six months duration was described by Wilkes (98),

and the diagnosis in tbe latter case was confirmed by

an autopsy.

Nevertheless, it was not until 1910 that

the name Streptococcus virid�ns was applied to the
organism most cormnonly isol�ted f'rom these cases.

Schottmtiller (83) at this time described the clinical.
features of the disease under the name "endocarditis

lenta�, and cited five cases in which the blood cultures
were found positive for the endocarditis cocci, which
he termed Streptococcus vfridans or Streptococcus
mitior.

He divided all streptococci (excluding the

Streptococcus n:ucosus) into two types according to

their manner of growth on blood plates and in blood

bouillon.

The one type, which he termed Streptococcus

longus, was described as producing fine, long, g rey

colonies and a clearing �f the media on blood plates,

and a carmine or burgundy red color in blood bouillon�
The other type, which he isolated from cc..ses of sub-

acute bacterial endocarditis an1 thus termed Streptococcus
viridans, was described as producing fine grey or

black-green colonies and no clearing of the media
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on blood plates, and a brownish-red discoloration in

blood bouillon.

He believed that this latter type

was specific for subacute bacterial. endocarditis.

In 1910 Libman and Celler (56) also isolated a

typical cocci from cases .of subacute bc.cterial endo

carditis, and likewise gave them the name Streptococcus
viridans.

However, _previous to this time the strep

tococci had been classified into five groups by Andrews

and Horder (1), and it was stated tba t the streptococci

isolated from cases of endocarditis were either StreP

tococcus salvarius or Streptococcus f'ecalis, and could

be identified by their cultllral and f'ermentative proP
erties.

The Streptococcus salvarius and the Strepto

coccus f'ecalis were described as being very similar,
and differing only in a matter of' degree.

It was also

stated that both types were short chained, grew fairly
readily in gelatin at 20 ° Centigrade, formed hydrogen

su1f'ide in broth culture, had no hemolytic properties,
and usually failed to clot litmus milk, but could be

differentiated by their power to ferment carbyhydrates.
The Streptococcus salvarius \vas found to ferment sac

charose, lactose, and sometimes raff'inose, whereas

the Streptococcus f'ecalis also f'ermented mannite in
addition to those already mentioned.

However, these

-4fermentation reactions did not agree with l�ter reports
(13) which indicated that the streptococci isolated

f'ran cases of subacute bacterial endocCJ.rdit.is nearly

alW&ys failed to ferment mannite, but did ferment.all

other sugars.

Thus Libman and Celler (56) came to the

conclusion that the classif'icat.ion of Andrews and Horder
(l) could not be accepted.

There was also another idea preVious to the report.a

of Libman,(56) and Schottmtiller (83) which proposed that
the organisms isolated from c�ses of subacute bacterial
endocarditis, although similQr in morphology to strep..

tococci, were actually pneumococci�

This theory was

set forth by Rosenow (81) after he had studied the

blood �Jltures from 14 cases by me�ns of immunological
and experimental tests.

He also proposed the idea that

the contraction of the infection which often lead to

death in these cases was due to a process of bacterial

immunization ag�inst the antibodies of the host rather
than to the virulence of the infecting organi�s.

Dr. Billings (4) also agreed with Rosenow, and stated
that pneumococci were the organisms most commonly

isolated from cases of subacute bacterial endocard.itis.

However, all other reports have failed to agree with

this theory, and the present day opinion can be sunmed
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up by quoting the following statement which was made

by Libman and Celler (56), "The agglutination and op..
sonic studies of Rosenow do suggest a relationship
of his orgQnisms to pneumococci, but until the orgaIP

isms are seen to have definite pneumococcus ch�racters,
they cannot be sure..ly classified as pneumococci."

At the present time it is fairly well agreed upon

by most observers that the Streptococcus salvarius

an:l the Streptococcus fecalis as described by Andrews
l,1Ild Hord.er (l), the pneumococci as deacribed by Rosenow
(81), and the organisms described by Schottmtiller (,83.)

am Libman(56) are all related to each other, am

should be considered as species of the non-bemolytic,
"green-producing" Streptococcus viridans.

And all of

these organisms regarciless of the species should be

classified under the general heQding of alpha-hemolytic

streptococci. (11)
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BACTERIOLOGY OF THE ALPHA-HEMOLYTIC STREPTOCOCCUS
The morphological features of the Streptococcus
virid~ns are about the same regardless of the species
•

or strain under consideration.

It bas ~lw~ys been

described as a gram-positive organism, and has never
been found to have a capsule.

It may either be round,

ovoid, lancet-shaped, or bacillury in form, and may
be found singly, as diplococci, or in chains.

However,

it tends to be lancet-shaped in the majority of cases,
and is more often arranged in the form of diplococci.
(48)

The organism varies in size from six tenths to

one micron in its longest diameter, and the number which
are present in the peripheral blood varies to s uch a
degree that there is no relation between it and the
severity of the disease.
The Streptococcus viridans organisms have been
found to grow best in a temperature of 37° Centigrade,
and it often takes as long as six days for the growth
to appear.

It has more recently been stated that cul-

tures should be watched for as long as two weeks before
they are considered negative, becuuse of the inhibitory
influence which the blood has on tbe growth of the
organisms. (32)

This is in contrast to the former
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opinion that. the delay in growth of organisms de-

pended upon the penetrating power of the organisms rather
than the· inhibitory factors of the blood. (100)

The

organisms have been :found to grow best on media which
contain trypsin or. sodium citrate.

The addition of lactic

acid offers no improvement, and likewise no advantages
are derived by the creation of anaerobic conditions.

The use of veal broth with the addition of trypsin

or sodium citrate will usually permit growth of_ the

organisms i£ they are present even in such small.numbers

as one to two per cubic centimeter.. -If- there is no

growth on this type of media, streptococ-ei are consider
ed to be absent fran the cultnre.

(100).,

As has olready been mentioned the ·streptococcus

viridans group of organisms are usually found to pro

duce a green hemolysis on blood agar. (48, 56, 69, 83}
There is ·rarely any clearing aroU'nd the grow;t.as, but

when it does occur, it takes two to four days to develop
whereas

the hemolytic streptococci develop a clearing

zone :very rapidly.

The original. colonies are sometimes

white in color, whereas the subsequent cultures usually
show the production ·of a green�sh pigment. (56)

The Streptococcus viridans organisms can be differ

entiated :frcm the pneumociocci and the• Streptococcus
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muc·osus by the smaller size of the growth s, the absence
of a capsul e , the inability to ferment inulin, a~d the
fact that they are insoluble in bile.

This latter

characteristi c is the most important di~gnostic fe a ture,
because although pneumococci may lose their capsules
or their inulin fermenting property, they have never
been known to lose their property of being bile soluble.
(14)

There are sane strQins of Streptococcus viridans

which do ferment -inulin, ~nd thus this cannot be depended upon a s a diagnostic charac t eristic.

Thirty

five cases have been re ported in which one-third of
the organisms were f ound to ferment inulin. (56)

Another

point of differentiation is that the Streptococcus
viridans orga nisms nearly a l ways produce a precipiu.te
in serum-glucose agar, whereas pneumococci rarely do.
It has also been pointed out that nearly all strains
of Streptococcus viridans fail to liquify gelatin, but
do produce acid in litmus milk. (48)

The

Streptococcus

viridans must also be dir ferentiated from the Streptococcus pyogenes, which is the cause of acute bacterial endocu.r ditis, but this is ea sily done by the
absence of a green growth an blood ag~r in the case of
the l a tter organism.
The properties of the endoc a rditis cocci also
remain constant for as long as eighteen months after
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subinoculations are carried out, and it has been found
that these organisms are not very pathogenic for animals.
However, peritonitis has been produced in rabbits and
mice by pe ritone al injections of cultures from actual
cas es of subacute bacterial endoc ~rditis. (56)

Endo-

carditis h~s also been produced in rabbits, but several
inocul ations are alw~ys required to produce the lesions.
The morpholog ical and biochemical characteristics
which have just b een described can be applied to any
of the species of the viridans group , however, it seems
worthwhile ~t t h is point to describe in as much as
possible the differentiating features of each s pecies
of the virid~ns group according to t,.~e most recent
classification which has been made. (84)

This classi-

fication is based entirely 9n their physiological properties, of which there are certain common characteristics
vmich justify their inclusion in this group.

These

characteristics are an inability to cause true hemolysis
of blood, the posssesion of a high minimum and a relatively high maximum temperature of growth, a weak reducing action, a limited tolerance to methylene blue,
s ~lt, and alkali, and the inability to produce ammonia
from peptone .

The org~nisms a re divided into the follow-

ing classes: Streptococcus salvarius, Streptococcus
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equinis, Stre pt ococcus bovis, v~rietie s of the StrePtococcus . bovis and 5tteptococcus thennophilis.
The Stre ptococcus s alva rius w~s first described
by Andrews and Herde r (1), and t heir description , which
ha s alre ady been mentioned, is very similar to t.~ c
present day description of the organism.

This particu l a r

species is most commonly found in the human throa t
a s well

ctS

i n the blood culture s from c~ses of subacute

bacterial endoc arditis.

It is diff erent i a ted from

the Streptococcus mitis, which is com.~only found and
not con sidered as a viridans organism, only by the
f act that

~~ e

latter fennents s alicin whereas the

Stre ptococcus salvarius does not.

Thus there is no

rigid demarcation between these two organisms, c:.. nd

the y can hardly be classed as separ ate species a t the
present time.

It must also be remembered that t..oe se

non-hemolytic streptococci of t he human mouth and throa t
probably form a rather complex group which will no
doubt be found to contain more than one s pecies ~fter
more penetrating meth ods of study bave been deve10, ed.
The Streptococcus s alvar ius is described as an ~cidproducing organism which g i ves a ph value of 4.4 to
4 in gl~cose broth, and readily acidif i es and curdles
litmus milk.

It also reduces li:t;,mus milk a fter the
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curdling or coagulat i on bas occured.
In contrast to the Streptococcus salv~rius, the
Streptococcus equinis grows poorly in litmus milk,
has a very slight reducing a ction, and less frequently
ferments r affi nose and inulin.

The Streptococcus equinis

also has a higher maximum temperature of growth , and
a slightly higher thermal resistance th an the Streptococcus salvarius.

The main point vfu ich differe ntic.tes

the Stre ptococcus equinis from the other four types of
the viridans group is t hat it does not ferme nt lactose,
whereas all the other members of the group do.

This

organism wa s also first described by Andrews and Horder
(1), and was s o named because it wa s first isola ted
from fresh horse feces.

Since that time it has fr~quent-

l y been obtained from the human mouth, from the urine,
and also from infectious processes including subacute
bacterial endocarditis.

Whether or not the se strepto-

cocci which have been isol.:. . ted from human sources are
the same as t hose of the equine origin cann ot definitely
be s tated.

In recent ye a rs the only requ irement for

an organism to be classified as Streptococcus -equinis
is that it be a non-hemolytic streptococcus which fails
t o fer ment l a ctose and mannitol.

However, the f ~ilure

to ferme nt mannitol is n ot a diagn-0stic f ~ctor, because
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the other four members of the viridans group have all
been known to fail in this respect in some c~ses.
The Streptococcus bovis differs from both the
Streptococcus s c:.lvarius and the Streptococcus equinis
in that it has a higher thermal death point, hydrolizes
starch, more frequently ferments raffinose and inulin,
and usually ferments arabinose
~

.

This streptococcus

was first isolated from cow feces, which is indicated
by its name, and has more recently been found in human
feces.

However, althcugh it is a member of the viridans

group, it is usually considered as being non-pathogenic,
and it is a question as to whether or not it may occasionally be found in human infections.
The group of viridans organisms classified as ·
varieties of the Streptococcus bovis are almost identical to the true Streptococcus bovis itself except that
they do not liydrolize starch, nor ferment arabinose .
It is also a question as to whether or not any of these
varieties are ever isolated from human infections.
The fifth member of the viridans group which is
known as the Streptococcus thermophilus is a a very
distinct type, and has certain physiological characteristics wh ich differentiate it clearly from any 01.h er
known streptococcus.

Although no knovm streptococci
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are truly thermophilic, the Streptococcus thermophilus
grows very a ctively a t

so° Centigrade, but growth. does

not t (.'., ke plt...ce at 53° Centigrade.

Its habitat is not

yet knovm, and it has never been obtained from clinical
sources.

Although its temperature requirements for

growth might suggest that it is an intestinal organism,
there is no proof that this is its s ource, and up to
the present time the Streptococcus thermophilus has
been isol~ted only from milk and milk products.
In summary it can be concluded that of the five
org~nisms belonging to the viridans group under the
Sherman classifica tion (84), only the Streptococcus
salvarius and the Streptococcus equinis can be considered as possible causes of the development of subacute
bacterial endocarditis.

However, the Streptococcus

fecalis which is a member of the enterococci group of
streptococci has also been isolated from some cases of
subacute ba9terial endocarditis.

This streptococcus

was also first isolti ted by Andrews and Rorder (1) who
described it as being non-hemolytic, having a strong
reducing action on neutral red, causing a coagula t i on
of litmus milk, and a fermentation of the disaccharides
and mannitol, but not inulin, and usually not raffinose.
They isolated it from human feces, and since t Lat time
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it has been recogn ized as the most character-istic
streptococcus of the human intestine.

More recen tly

(84)_ it hc..s been shovm that with respect to its fermentation reactions, the Streptococcus fec(;.lis shows
great diversity, becaus e it m1::..y or may not ferment
arabinose, sucrose, r affinose, and glyc erol.

The fer-

mentation of mannitol has long been considered as a
constant and diagnostic feature of the Streptococcus
fecalis, even though a few strliins f ~il to do so.
And although the Streptococcus fecalis is not usually
classified as a pathogenic organism, it has been
recognized since 1906 as occasionally giving rise to
sub~cute bacterial endocarditis. (1)

In a recent review

of the literature 37 cases of subacute bacterial endo-.
carditis were reported in which positive blood cultures
for the Streptococcus f'ecalis were obtained. (85)
Twenty more cases are also recorded in which the causative organism was thought to be a member of the enterGcoccic group. (70)

Thus it is a question as to whether

or not the Streptococcus f'ecalis is a member of the
alpha-hemolytic group of streptococci, but nevertheless
it is a cause of subacute bacterial endocard ~. tis in
some cas es.
Very recently a new variety of non-hemolytic

-15-

streptococcus has been isolated from the blood o:f patients
suffering from subacute br. cterial endocarditis, and
it has been given the name Streptococcus •s.b.e., because of the fact that it has been found only in this
one type of patient.

And up to the present time 42

cultures have been reported from 36 cases of endocarditis.
(96) .The name Streptococcus sanguis has also been
suggested, but as yet is not being used.

The Strepto-

coccus s.b.e. is not just a collection of unclassifiable org~nisms, but actually displays homogenous biological and i rrmunological characteristics, and is more
often isolated from those cases which fail to show
any response to therapy.(59)

This new type of strep-

tococcus nearly always produces a green pigment on
blood agar, and has been proposed as a new member o:f
the viridans group which would ..also allow it to be dlasse d
as a member of the alpha-hemolytic group o:f streptococci.

In confonnity with the viridans group as defined

by Sherman (84) none o:f the cultures were capable o:f
initiating grovrth at 10° Centigrade, but half of 1l1 em
did so at 45° Centigrade.

Likewise this new strepto-

coccus has been found to ferment inulin, but is ncnsoluble in bile.

However, 30 of the cultures of the

Streptococcus s.b.e. have been found to grow satisfacto-
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rily i n blood agar containing 40 per cent bile (96),
and the other members of the viridans streptococc i
will not do this.

The fact ti at t h is streptococcus

is somewhat tolerant to bile sugge s ts tha t it might
be an inhabita nt of the human intes t ine, but no recorded
attempts have been made t o isola te it from this source.
The ferme ntation of irrulin i n combination with the
failure to ferment r affinose and ~rabinose h~s proved
to be a very character istic findir,g .

It has also been

found to hydroli ze arginine in contrast to any of the
other established species of the vir idans group.

How-

ever, the Streptococcus mitis, which is commonly found
in the throat and is not a member of the viridans
group, also hydrolizes arginine, and thus must not
be confused with the Streptoc occus s.b.e.

It has also

been re ported that the Stre ptococcus s.b.e. has the
ability to synthesize large amounts of dextrin in broth
containing five per cent sucrose, but not in sucrose
agar. (72)

Although this may be an important identi-

fying feature, it is not specif ic for this organism,
because seven culture s of the Streptococcus bovis have
also been found to synthesiz~ polysaccharides. (72)
There. is also the possibility tha t t he Streptococcus
s.b.e. may synthesize dextrin in either broth or agar
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containing five per cent sucrose, if the cultures are
incubated anaerobically. (33)

• these

Serologically none of

organisms could be placed in any of the beta

hemolytic groups.

It would be very important !ran the

standpoint of prophylaxis and therapy if the habitat of

this new organism could be found, however, all attempts

to isolate this organism from t.he mouth and throat have

proved negative.

Nevertheless, it wc.s isolat.e-d by

accident in one case from a masillary sinus washillg,

and also from an extracted tooth of a patient who defi

nitely had subacute bacterial endocarditis. (96)

organism deserves future study before its definite

This

position 'in relation to the disease, subacute bacterial
endocard.1tis, can be determined.

From the standpoint of therapy it woul.d be very

helpf\11 if these species of the viridans group could

be definitely classified so that the virulence of the
various members and their su.scepttbility to various
drugs could be determined.

However, as yet no standard

olassific�tion has been established, but an attempt

will now be made to review the di:f'ferent ciassifications
which have been proposed.

Following the work of Libman and Celler (56) one

of the first attempts to class1.fy the bacteria of the
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viridans or ngreen-produc ingu group was made in 1917
by Blake. (5)

All the streptococci were divided into

two groups known as the Streptococcus hemolysus and the
Streptococcus viridans.

The Streptococcus viridans

organisms were then divided into the Streptococcus
bucallis, t~e Streptococcus fecalis, and the Streptococcus equinis.

This classifica tion was based upon

the fermentation re~ctions in lactose and mannite as
is given in Table 1, and is very similar to the classification made in 1906 by Andrews and Horder (1) except
that the Streptococcus salvariu? is here spoken of as
the Streptococcus buccalis, and the Streptococcus equinis
is considered as a member of the viridans group for

the first time.

However, there were some clinicians
Table l
La_tloae

Matm.ite

Streptococcus fecalis---fermented

fermented

Streptococcus buccalis--ferrnented

not fermented

Streptococcus equinis---not fermented

not fermented

who did not believe that the fermentation reactions
could be of much value, because in some cases they
failed to correspond to the differences in action on
blood agar. (44)

This quest:i.on of fermentation reactions
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is still at the present time a debatable question,
but nevertheles s all of the non-hemolytic,"green-producing" stre ptococci isol1:.ted from c ases of suba cute
bacterial endoc~rditis have now been established as
belonging to the alpha-hemolytic group regardless
of their carbohydrate . fermentation rea ctions. (11)
No further attempts at classific a tion on th&
b~sis of physiologic al and biochemical re ~ctions were
made until 1937. (84)

And although this classification

is not recognized as a standard cla ssification of the
virida ns group of organisms, it is the latest classification which has been made, and is constantly refErred
to by all qf the modern bactEr iologists who have worked

with this group of streptococci.

In this classif ication

the viridans streptococci are divided into five groups
on the basis of their physiological r eactions which
have already been described.
The most recent c.dvance s i n cla s s ifica tion have
been on a serologica l bas is.

Although agglutination and

and complement fixation antibodies were described

a s being present in some cases of suba cute bacterial
endocarditis as early as 1912 (64), many cases of endocarditis due to the alpha-hemolyti c streptococcus were
reported before the development of the present day
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group precipitat ion techniques, and thus d&ta available for a serological classification is somewha t limit,

ed.

One of the earliest re ports of work being done in

this field was in 1925 (36, 52), and at this time two
types of antibodies were found to be presen t in the
blood culture of patients suffering from subacute b~cterial endocarditis.

One of these was an antibody against

the bacterial protein, and the other agains t the nonprotein fraction, which· was probably the ca rbohydrate
fraction of the bacteria.

By the use of agglutination

and complement fixation tests, it was decided that this
antibody against the non-protein fraction of the bacteria
was type specific for the viridans group of streptococci,
but not species specific.

It, was also stated that

there wo.s a group crossing between the non-hemolytic
streptococci isolated from these ca ses of endocarditis,
and the hemolytic streptococci which were isolated from
other types of infection.

It was more than ten years

before any more work was done in this field, and it
w~s then established th~t some of the alpha-hemolytic,
"green-producing" streptococci isolated from cases of
sub~cute bacterial endocarditis contain a common antig en which enables them on the basis of serological
tests to be pl a ced in one of the beta-hemolytic groups
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as established by Lancefield in 1925. (52)

It has

been found that t here are four distinct serologic&l
grou? s of beta-hemolytic streptococci ( 25, 52) known
as Groups A, B,

c,

and D, the l a tter being the group

into which some of the stra i ns of the alpha-hemolytic
streptococci may fall. (94)

There are several recent

re ports in t he literature of a ttempts at serological
class ification of these particular members of the alphahemolytic group, and since the results are all quite
similar only one of thes e will be described in deta il.
Solowey (90) isolated strains of Strept.o coccus
viridans from 108 cases of subacut e bactEt'ial endocarditis, and for comparison 99 stra i ns of Streptococcus
viridans

isola ted from the throat and extracted teeth

were also studied.

Of the total 207 strains of Strep-

tococcus viridans, although only two strains (one from
a case of subacute bacterial endocarditis and one from
a throat culture) fell into one of the beta-hemolytic
groups, 14 of the remainirr~ 205 strains were classified
into s erolog ical groups.

Thus it appea rs t hat the non-

beta strains which can be classified as alpha-hemolytic
streptococci are sometimes identical serolos ically with
the beta strains, or at lea s t can be serolog ica lly grouped, ar..d it is difficult to s ay whether these organisms
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are alpha or beta, and some clinicians in this field
(25)

do not believe that they can rightly be called

Streptococcus viridans organisms.

However, since there

is no correlation between the agglutination or complement fixation tests and the biochemical reactions (90,

94), the serological classification is of no apparent
value except that it demonst1"8.tee the diversity of the
non-hemolytic streptococci in contrast to the relative
homogeneity of the hemolytic types. (17, 46)

Thus

it appears that there is no advantage in classifying
these organisms according to their serological reactions,
and it remains for future study to determine the 1)ossible
advantages of the serological classification.
50 per cent of the 16 serologically grouped strains
mentioned above (90) were frcm the throat and extracted teeth cultures.

And 80 percent of the strains from

the subacute bacterial endocarditis cultures together
with 60 to 75 per cent of the strains from the :th-roat ~
and teeth cultures were classified as Streptococcus
salvarius, the rem::tinder of the strains from each source
beine placed in a heterogen ous group.

This suggests

that :fhere is no difference between the streptococcus
found in the throat, infected teeth, and in cases of
subacute bacterial endocarditis.

However, it is possible
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that they only appear to be the same organisms, because
no methods have been developed to differentiate them.
If it i J accepted that the organisms in the throat
are the same as those isolated from cases of subacute
bacterial endocarditis, the prevalence of the organisms
in the mouth and the ease with which they enter the
blood stream may be considered as the basis for the
development of the endocarditis.

It has been reported

by Okell (73) that 75 per cent of patients with septic
mouths, and 38 per cent of the patients without any
obvious dental infections will develop a bactcremia
after dental manipulations have been carried out.
And it is well knovm that the onset of subacute bacterial endocarditis is frequently associated with a
preceding acute upper respiratory infection or tonsillitis. (57, 93)

The Streptococcus viridans organism

has also been isolated from root abscesses at ~a . time ~
when it was also present in the blood stream. (9)
A group of 347 cases (23) has also very recently been
reported in which 10 per cent of t he cases had teeth
infections, and 10 per cent dental manipulations before
the onset of the subacute bacterial endocarditis.
Thus although it is still a question as to whether the
organisms from these various sources are the

SciIIle,
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.
it is nevertheless a very import<:.nt point to remember
from a prophylactic ? Oint of view when de~ling with
any patient who is suspected of having injured or ab-

normal heart valves.

-25-

EJi.?.LY T.r<::E?i.A.i'Y ••GAILST S U:3ACUTE BACTE:1HL ErDOCAHDITIS
Up until recent years subacute bacterial endocardi
tis had been considered a fatal disease.

However, with

the advent o f the sulfona'�:ides and penicillin
the incidence of supposed cures has greatly increased.
Nevertheless, at the present time we tend to be over
enthusiastic in considering the incidence of cures,
for we must remember th&t the patients who do recover
have added additional d,;mage to their aL"eady deformed
heart.

This not only limits the )atient's future

physical activity, but also increases the likelihoo d of
rei nfection.
One o� the first forms of therapy for cases of
subacute bacterial endocarditis wus the use of human
imrr.une trar;.sf'usions.

A vaccine vms first prepared
y

fro m the patient's organisms as ti1e; were found in

the blood stream, and they were then killed by merthi
olate, dilute6 in normal saline, and injected subcu

taneously into volunteer subjects, usually relatives.

Blood fran these volunteers was then given to the patient
either by direct transfusion, or by injection of blood
serum.

Heyd (35) in 1917 was one of tb.e first to report

any success with this method.

He reported that his
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patient was given "about six transfusions :from 200 to
;::50 cc. 11 from a donor who previously h..,d received an
injection of vaccine from the patient's organisms, am
that the pa.tie t

'Wi.:l.S

However,

cured in three months .

this case cannot be accepted 1;;.,s ,. cured case , because
there are insu:fficient details to prove that ttiis is a
definite case of subacute bacterial eng.oc&.rditis.
wring the period from 1917 to 1929 Lamb (51),
Hov1ell (38), Wordley (99), and Kurtz ( 50) also report
ed cases in which this fonn of tLerapy was used, but
without any success.

Even �s late as 1937 Kilgore (43)

treated three cases in a simil,.tr· manner.

All three of

his cases shov-,ed temporary improvement in thct there w as
a relief of the anemia, how ever, the blood culture
remained positive all during the course of the
tre&tment.

Embolic symptoms and fever also continued,

and all tr.ree of the patients fin�lly died.

Thus it is

fairly ,Nell proven that the use of' human immune
ser·um is of little value in the treatment of subacute
bacterial endocarditis.

Lamb (51) even used serum from

an immunized horse, which also proved to be
ineffective.
Aside f'rom the early immune transfusions, tl1ere were
also other bazaar forms of treatment w hich are
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interesting to note.

Among these mit,ht be mentioned

some various forms of treatment vJhich were tried at the
Peter Bent Brigh am Hospital in Boston between the years
1913 and 1944. (23)

One of their cases was given rat

bite fever, and another oalari� in an attempt to cure
th e disease by producing an arti:fici&l hyperpyre:xia.
Bacteriophages were also injected intravenously, and
in one case turpentine vms injected intramuscularly
for the purpose o� producing sterile abscesses.

The

breast o:f one patient WLS even resected followea. by
a searing over of th e pectoralis mujor muscle.

The

be.sis for these various forms o:f so called therapy
is not given, e..nd they sound rather peculiar in the
°

light of our preser:t day knowledge, however, they we1 e
actually used at one time in a desperate attempt to find
some means of cure.
The treatment of subacute bacterial endocardi tis
can actually be divided into two eras: first that pre
cediri.g the advent of the sulfonamides and pe,dcillin, and
second thi.;.,t :following the advent of' the sulf'onamides and
penicillin.

Prior t o the use of the sulfonamides in 1927

the reports of' cure are quite rare, and are considered
by many clinicians c::.s being cases o:f rheumatic
endocarditis rather than subacute bacterial

endocardi tis, because of the insuff'ic :Lent evidence to
def'initel y diagnose these cases.
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SUSC"EFTIB rLITY OF ALPF.A-IIE:MOLYTIC STREPTOCO CCUS TO THE
S1}LF01TAMIDES

It seems worthwhile at this point to review the
experiment&l vmrk whic11 has been done in evaluL-ting
the efficiency of the sulfonamides in the treatment
of sub&cute b&cterial endoca�ditis bef ore discussing
the c..Ct'..lal results which 11ave been ,:fotained in the
treatment of p&tients suf:ering from this disease.
The experiment.::..l work can be divided into the in vivo
and the in vit;:·o studiE:is.
The in vivo method wo;).ld be very good if the endo
carditis lesio=�s cou1d be established unquestionably
in the experL111enti::,.i.. u.nL'Tlccl, and still the animal survive.
However, there are several reports in the literature
of' the succes,-::ful production of' t.'l-iese lesions in dogs
and rabbits.

One of the firs reports was in 1916

(21), in ,.·rhich rabbits were given intravenous injections of
bacteria vihich were obtained f ro"'.ll the blood of patients
suff ering from subacute b�cteri.al endocarditis.

It

was fo�nd that although the bacteria, which were iden
tified as strains of the Streptococcus viridans, were
of low virulence, lesions could be produced in the
rabbits \'Ihich were near iy identical to those found in
the patients from v::;10se blood the org�nisms had been

isolated.

It w as also :fotnd at the scJne tL"lle that

the Streptococcus viridc;,nS organisms isoli:c.ted :from
the mo:.·ths o:f normal individuals were also capable of'
producing heart lesions in rabbits, which is further
evidence t::at the organisms resi:)onsible f'�;r subacute
bacterial endocarditis &re the same as those found in

the mouth and throat.

Endocarditis was successfully

produced in dogs (45) by first injuring the aortic
valves by insertir.g an instrument int o the left carotid
artery, and then after the valves had been in ._iured
the Streptococcus viridans organisms were injected into the
dogs intravenously.

Endoca:·ditis has also been produced in

dogs by setting up a bacterial focus in
the cardiac cavity. (28)

This was done by inserting

ba..'!.:::e lite ca_1sules conta.inine blood agar cultures of'
Streptococcus viridans through the thoracic w all and
directly into the cardiac cavity.

It l:..as more recently

been frund fu[, t experimental endocarditis ca n be pro duced
in rabbits by intravenous injections of the bacteria
without any accessory injury to the animal. (61)

Howeve

r, since there is no definite way or determininf.: the
presence of valvular lesions in tr.ese experiment al
&nimals, it is also ver-f dif:icult to determine the
efficien cy i�f the various therapeutic measures by the
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means o:' these in vivo tests •

And thus .:...t the present

time the in vivo tests hc:.ve been C".Uite generally
re;il&ced by the in vitro methoas of study.
The greatest advantage of the in vitro tes,, is ttu1t
it of'f'ers Z:c.n index of the degree of br,ctericidal or
bl..cteriostati c power of' a irug by i ts :.n::t�uence u J.1on
the bacteric;,l gro·wth curve.

This w...,..s pointed out by

an experioent (75) in vrh ich t:~1e growth curves of
bacteria inoculated into human marrow cdltures were
observed

:f'ollowing the introducti or: of antibact::crial agents.
However, the in vitro method is of limited value in
the stud:- of the organisms responsible for subacute
b0.cterial endocarditis, because of' the indefinite role
of the fibrin barrier in this disease.

This idea that

the fibrin factor must be considered in all in vitro
analyses of' therapeutic agents -..•.ff,.:.. ::'irst pointed out
by Friedman and his co-workers. (28)

They inoculated

plugs of f'ibrin with broth cultures of' Streptococcus
viridans organisms, �nd then pl&ced these plugs in
media containing antibacterial 1:�gents in established
ranges of' concentrati on.

These medic. were observed

at 24 hour intervals over a 120 hour period, and the
bacteria were found to survive longer and in higher
concentrations of the drugs used then in the control
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series in vrhich t h e bacteri2;, were olaced directlv into
medic:.. co:.:tc. ining t1:e e.:i.tibc,cte rial ,.:..gents, thus omitting
the fibrin.

Likewise at the su,.�e time Streptococcus

viridar:s organisms were also inoculated into serum
suspensions of white blood cells, and it was found ttai:,
the streptococci would not grmv in t:cis type of culture.

Thus it wc..s concL1ded that the persistence o�· the
infection in these cr,sEs of subacute bc.cteric�l
endocarditis we:..s d ue to the fact that the fibrin depos its
exceed the white blood cell invasion, and also o:f'i'er c:..n
excellent media for the growth of the orgc.. nisms.

And

thus since there is no evidence t..1-iat the bacter iu. acquire
resistance to the action of the �nite blood cells, nor
t..�at the latter lose their power of destroyir...g the
bacteria,
the fate of the infected focus seem to depend u;,on
the balance o:f the fibrin deposit t..nd the v-mite blood

cell infiltration.
Fost-morten examin:..,tions have shovm that the
platelet and cellul<-.r thrombus, whicll becomes the seat
of bucterial infection in cases of subac t e b6.cte rial
endocarditis, is actuall:, a friable vegetation wit::1 a.
suppur[,tive framework of fibrin.

Thus since this mass is

de finitely not c. solid structure, it ht:.s been pro
p osed that it p robably contains fissures a.nd. cracks
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so the-. t the bc::.cteric. 8.re sepo.ratec. from the blood stream
by a mesln';ork of fibrin-gel cont.:.. ining blood serum
or ;:;L.,0.SmE�. (92)

It

111rus

also proposed th

there

&re

probc:.bly c1:annels o:f com:nunicatior between the deeper
parts o:f the vegetations and the blood stream, because
otherwise the bdcteric could neither survive nor gain
exit to the blood stream.

However, there is always the

possibility of 11bacteria-free11 cases to consider (55),
b ecause in these cases although the bucteri& become
sealed off and die the clinical _;:icture of the disease
persists.

l'evert11eless, it was concluded that bacteria

do become lodged in this serum or plklsma fibrin-gel
r:1eshwork (92), and thus a---iy chemotherapeutic study of
ageEts to be used in the tre;:,.tment of subucute bact
eric�l endocarditis must tl,ke into consideration a. stucy- of
the relationship of the fibrin meshworl::, the surroundir,.g
media, and the b lood stream.

\Vith these con

c lusions in □ind a new· in vitro method ViciS d evised ( 92) v;hich
consisted of t:he conversion of' f'ibrinoge:ri in ci tratea. dog
plasm.a to fibrin by the s.ddi tion of calcium chloride, a.nd
tb is was then inocuL:;;.ted. with Streptococcus virido.r:s
org&nisms, cmd sus::-:ended in a medium containing th.e dru£
in questior..

The fibrin produced in this mar:.ner was

thought to be very simil&r to the
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fibrin in the blood stream.

After a period of incu

bation, the fibrin column w,�s removed, ground with
.
s&no.� , 0.1.
�.,.... uted 1.n
. norm.c;. 1 sa..1�.1ne,
and t'rien incubhted
as a poured blood E-gar :Jlate, Cl,nd colony counts were
then

mad.e

v:hich

indicated

the

of the drugs ·which vrere tested.
·was

bacteriological

action

In this manner the :fibrin

found to be penetrable to both sufanilimide and

neoarsphenamine.

However, thE· inhibitory actic.n of

the latter was sl i[-t.tly greLter, ar.d it v.rfas thou. ht
ttis.t the inhibitorJ action of both of the d.'l"'Ugc 11:ould
be greater in t..11e presence o:f the cellular ele·; e nts of
the blood.
The first actuc..l reports of in vitro tests being
made :for the purpose of determining the bacteriostatic
effect of the sul:font,.r:.ide drugs upon v&rious strair:cs
of the Streptococ cus vir'. dans was published in 1938 by
Bliss. ( E)

At tids time it was stated that most of'

the strains of' the Streptoc oc cus viridans were
rus�pti'ble to a one to 10,000 concentr�tion of sulfa
nila.mide, and it was later remir ked that the resistart
str&.ins beloneed to the Streptococc1....s :fecalis clc.ssi
fication. (71)

These conclusion s were modified by

another report vJhich st&ted that the
alpha-hemolytic streptococcus could be inhibited by
the sulfonamides
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only in the presence of' an. adequate number of leucocytes
(63), and thi..t the streptococci were more oi'ten inhibited.
if the incubating temperature w&s m2..L,tai ned near 40°
CeLtif·rc.de. (29)

However, ,~t about tLe same time, and also

following t1:is time, there were other
re:!ortr, which �ndic2ted that the sul:f'oLamide s hcid lit tJ.e
e:fect upon the alpha-hemolytic streptococci in vitro.

(3, 10)
It wr-s L....te:::· rec,,,lized that this wide variation of'
results \Nas due to the fact that the various strains
of' ti"le Streptococcus viridc,,nS differed in theL· sucep
tability to the sulf'ona.�ide d.rtle;s, and thus reports
began to come out in which the SlSCe;.Jtibility o�� the
various straim, were compared.

In one such experime11t

blood cultures ·were taken :form eb.ch of :four c ases, and the
four strains obt&ined were then tested in vitro
with the various drugs, 2..nd the e:f'fect upon each strain
was then compc..red wi tl. the effect produced by giving
the drug to the patient from whom th&.. t 1Jc-2ticular strain
had been isolE.ted. (90)

The three drugs which were tested

against these four strains ·of organisms are 4:4'dirunidophenyl sulphone, sulfc.py-ridine, and the soluble
sodium salt of sulfapyridine, an d it was found that there
w'l:;.s litUe difference in the acti-:m of' the three drugs.
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Two of the isolated strains of stre;;tococci proved to
be cuitE: rusaaptible to each of the three u.rugs, and
by this it is meant tl1at there eitLer was no growth or
onl:: c. very E-light growth e.t the end of 48 hours.
The two p1::::.tients from whom these strains were icolated 2:lso
seemed to be markedly influenced by the treat."!lent vdth
U1ese sulfor:mmid.e derivities.

The blood culture

in one of these Cto.ses beca::ie sterile and remained so for 33
days,

Ect which time the patient died; and the secorxi c&se

mc,;;,intained a negative blood culture for the first
10 days, but then it became positive.

The other two isolt.

ted strains of streptococci seemed to be resistant to ""11
three forms of therapy,

an d the patients :fran

vvhom t..'1ese strcdns were obtained also showed no cr.anges
after intensive courses o:f treatment hcd been carried out.
The morphological :features end the f'err.ientatio n reactions

o:f each of the :four strains were compared
and were stated to be quite different :from each other, but
no b.ttempt at classification vms made. 'However, there v·ms
no relation between t�1ese differences and
their ru.�eIJtibility.

After studying these results it

can ri,€·htly be concluded that some strains are susceptible
to the sulfonar:1ides whereas otherc; are resistant , and also

the strains which in vitro are resistant appear

to be the causative agents in the cases v;Lich ftdl to
respond to treatment.
thut

periods

oi'

However,

sterility

Cl.re

it must be remembered
relatively

common

in

subacute bacterial endocc..rditis,
and the coincidence
of such a period c�nnot be excluded. It c�n also be coneluded that the determiw".t ion of tJ1e drug susceptibility
of' the pt,rticulc,r str&in oi' streptococci in question is
an essential 1)relimirn_.ry factor in the treatment of every
Ci.:Se of' subacute bacterial endocarditis.
A comparison of the bacte�iostatic effect of the
sulfonamide drugs upon the growths of' 25 strains of
Streptococcus viridans ,•,as li;;.ter reported. (74, 79)
The inhibitory properties of seven sulfona1nide druss were
tested agairist tJ:1ese 25 str£;.ins, all of which were isoL:..
ted from the blood of patients ·who consistently
had been shovm to have positive blood cUl tur es.

The

results eh owed that t:_ ere vra s a great variation in the
effectiveness of these drugs against the various strains,
and there was also a great variation in the suscepti:
bilit;r of each strain to the various drugs.

Seventeen

of t}--- (".> 25 strains were inhibited by one or more of tlie
drugs, and three of these 17 strains were inhibited
significantly by all seven of' th€ drugs.

Seven of the

25 strains were not inhibited by any of the drugs,

and

the remaining strair_s showed corisiderable vari&tion.
Except for one strain, no drug was bLcteriostatic unless
the strain had also been inhibited by sodium
sulfapyridine, &"1d this pa:ticula1· exception was
isoL:,ted from a patient who had previously ::ieen treated
with
sulf'apyridine.
ma�" cause

This suggests tt1at in'-'" deq_uate treatment

the patient to build up

a.

resistunce to the

drug, and thus make any future hope for a succ0ssful
cure quite futile.

Table 2 (79) shows the percentage of

the 25 strains in which the growths were inhibited
after 24 hours in a concentration of 25 or 30 milligrcs.ms per 100 cubic centimeters of sul:fanilimide, sodium
sulfapyridine, sodium s-..:llf'athiazole, sodium s ul:fadiazene,
and of 7.5 to 10 milligrams per 100 cubic centimeters
of sulf'athiazole, SJlfapyridine, and sulf'Hdiazene.

Table 2

�_Of Strains Ir.Jlibited-Not

Ir..hibited sodium
sulf'apyridine-----------64---------------36
sulf�nilamide------------------60---------------40
sodium sulfathic.z ole-----------56---------------44
sodium sulfELdictzene------------43---------------52
sulfathiazole------------------44---------------56
sul:fapyridine------------------40---------------60
sulfadiazene-------------------20-------------64
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This table shovrs that al though there. was a great var�
iation in t.�e effectiveness of these drJgs, the sodium
sulf'ap;y-ridine did exhibit the :1ost r::i&.rked ef'fecti veness
in the greatest number of strhins.

This o.gc.in

emphasizes the im)ortance of determining the suscepti
biJ..ity of every· streptococcus b;, in vitro methods before
selecting the type of chemotherapy to be used.
In su mnary it can be said th,. t these experimental
stu dies do not of'f'er much hope :for an increc;.Ge in the
incidence of c�re of cases of sub�cute bacterial endo
carditis by the use of: these various sulfona:r:ide
derivitives.

1Tevert,heless, they have shovm that there

is a great variation in the susceptibility of' each
strain, but no conclusio ,s have ever been dravm as to
which strains are more often in..1-libited b;y these various
sulphonamides.

Thus the only fi:: :1al conclusion ·which

can be made is that if any of the sulfa derivitives are
to ":)e used, an in vitro test should first be made to
determine the susceptibility of tl1e pl.rticular strepto
coccu s in nuestion.
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THE USE OF Sl:JLFON•.J:IIDES IN THE TIB rtA.PY OF
SU13ACUY� BACTErtIAL El�OOCA?DITIS

The actual treatment of c�ses of subacute bact
eric.l endoco.rditis vdth the sul:fonwnides wa.s begun
after some of these experiment�l studies ru..d been carried
out.

The sulfonamides were :first used alone, but they

were soon combined with heparin, ,Jnd there is still
a c:uestion among different physicians as to which form of
therapy is the best.

Kelson a:1d ·white (42) were among

the f5rst to report the use o:f sul fapyridine
and hepa: in, and they based their use o:f the combir:.ed
form of therapy upon the work re;:orted by Wright in
1925 (100), who expla ined th�t the streptococci usually
lie ne,.-r the peripher; of the vegetution, the latter
being ccmposed mainly of' fibrin w ich serves as an
excellent culture media.

Thus Kelson and White (42)

concluded that it was nearly impossible to increase the
number of phagocytes and tl1us dissolve th e vegetat ons.
However, they did believe that thrombus formation on
theoe vegetations could be prevented, which would ir:. turn
restrict the c lture media, a nd also ;revent the
:form&tion of emboli.

It 'Wt:'.s this conclusion tht:,t led

ther:t to COII!.bine hep""rin with sulfc.:.pyridl.ne, the latter
being used for its bacteriostatic and possible bacteri-

-41cidal effect, and the former because of its
anticoagulant properties.

All clinicians ,<tio

administer heparin will c.gree upon this basis :foy, the
use of heparin,
but there is a present day tendency to believe tho. t
hep�rin gives no added advant&ge.
There ha ve been numerous reports of cures

i;;.Dd

failures ��ollovring the use of sulf'apyridine both with
a:'.�:d vlithout the e.ddition of heparir�.

However, ma:ny

of the cases cLm2ot be accepted becc,use of insuff'icient
crite ri� to establish a definite diagnosis.

Therefore,

o nly t1:ose c£"'s,: s which can be definitely diagnosed us
beil1,f.; subacute bacterial endocarditis, and which offer
some indicat_on of the effectiveness of the drugs used
will be discussed.

Kelson and VT.hite (42) reported

six cuses which showed more tl1c;..n four consecutive positive
blood cultures, and can thus sc.fel.r be c&lled c""ses
of subacute bacterial endocarditis.

Three of these

cases were made symptom free fol._ cwiI1[; the use of sulfa
pyridine 8.nd heparin, and they al£o showed no character
istics of t1-:.e''bacter ia free 0 cuses f.;.S described by Libman.
(55)
Le,ach
41 cases

and

his

associates

in vrhich chemotherap:-

in

1941

(53)

reported

and hepa:- in had been

used, and of these half vrere treated with heparin alone.

-42They re:;_:iorted th'"-t follov:ing the use of sulfap;yridine
there wc..s a remission of S?mptoms,

na. o.n hPDarent

permaner:t recover>J in 10 per cent of the. 41 C""S"'-S so
trec-ted.

Heparin W;,;,..S

of a::ip&rent recovel""'.-

sec. in threE of tr.ese cases
From tLese

&1.d

other Ci:,ses which

vier·e treated titey co1:cl1-ded thut hepc.,,,rin alone is in
effective, but wher: canbined with chemotl·J. erc�py is very
ef'fective.

From their experience -:.hey offe::.· the follow-

ing findings as supportive evidence of the value of
hepurin in t reat ing co.ses of subacute bacter ial endo

carditis: the greater incidence of s .ccess with the use
of combined thsrapy than wi th sulfapyridine alone, and
the unusual degree of healing in the vegetations of
.:,atient Yvho h,ave died during or shortly c:.fter the use

The present status of heparin in the treat
ment of s: bacute b<.�cteric..l endocarditis will be
discussed later in conr.ection vdth the use of' penicillin.
Foreign proteins have also been '..lSed in combination
with sulfa.pyridine, and have been reported as being
fairly successf'c1l. ( 37)

Their us,:; is based on the

work done by 1:Jhite and Parker (95) who po_inted out that
in vitro &t a temperature above 33 ° Centigrade, the
effect of sulfapyridine upon nan-hemolytic streptococci
was chE:.nged :from that of inhibition to sterilization.
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Thus the oral ad:".'linistration of sulf&pyridine vras com
bined with intravenous injectio ns of typhoparatyphoid seru
f'or the purpos e of producing a state of hyperpyrexia in
hope of renderin�� the combined treatment b1:.�ctericidal
rather then bacter-iostatic.

Solomon (87) treated seven

definite c,�.ses of' subucute bact!:l" ial endocarditis in t.11.is
m,�nner, five of which 2.re reported to have recovered.
There have also

been several reports

of fever therapy alone.

on the use

One of the first such reports was

r.:ade in 1937 by Dry and Vlillius. (22)

At this ti.'lle

it vras thought that induced hyperpyrexia might stimulate
cellulDr 'and immuno logic defense mechc.nisrns to over
come t.11e infection.

With this in mind the tempe- ature

of four proven c�ses of subacute bacterial endocarditis
at 106 to 107° Centigrade fo:c three
to :five ho urs :for four different periods, and eac1 patient
received six of' these trehtments.

The fever was weJ.l

tolerated, but the blood cul tu.res remained ;Jositive,
and petec'::1.iae actuall;t became more nu,. erous.

Thus

the treatment can be considered as being a failure
in these cases.

From their experience they concluded

t,nut the :fever does increase the def'ense mechanism,
but the orgardsms resist the hi,::hest temperc.ture to
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whic h it is sc-fe to ex::>ose the bodv
--

&,

No f\.1rther work

•

\'las done on fever therapy until 1933 when Bierman and.
Baehr (2) treated 16 cases in the same manner.

?xo

of' these cases recovered, and the others showed only
tenporary im)rovemer:.t.

Again in 1940 six more cases

(49) were reported as beins tre ::.ted ·wit h fever therc.p�

and S'.Jlfonaiilides, a."'1d all of them _::>roved to be fatal excent

. f'or.one case
fever

Thus it can "be concL.ded that
therapy ulone
or in combination
have

some

endocarditis,

but

sulfona.:ides
b acterial

ma:

influence
it s

upon

eff'ects

with

the

subacute
�.re

only

transient .
In su.i-mnary it may be said that the use of' all
sulfonamide drugs h2�s proven to be relatively
ineffective.

Sulphanilamide , sulfathiazole,

sulf'&diazene,
and sulfapyridine have each been tried, ur:.d the latter
seems to be the most ef'::ective.

It does produce a

tr,,nsient relief by lovverirl[; the temperature, and some
times even renders the blood cultu.res negative•

However,

through the experience of' many dif'f'erent workers in this
field, it has been found that the results last only
a few days or months, and the symptoms nearly �¼lweys
return after the dis continuation of' t11e sulfa regii-ne. The
m:.;ture of the foc,_,s of' inf'ection (89) is established as
the cause of the h1eff'ectiveness i n some cases,
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because tte bacteria are knovm to be located bene ath
the surface of the ve gett;.ti o:s, and are thus probably
protected f rom the sulfa in the blood.

Spink (89),

hoaever, also points out th2..t since the sulfonamides in
the blood may have a bactEr iost&tic effect on some
str�ins of Streptococcus viridans, sulfapyridine should
be given L,S a prophylactic to an patient with valwlai:
lesi ons before he undergoes any or�l surgery which
0

,

may very likely give rise to a bacteremia..,

There have

been ve.rious opinions -as to the cause of' the ineffective
ness of these sulfonamide drugs, and in 1945 the causes
were aptly summarized by Kelson (41) us follov1s: 1. com
plications of t.�e di sease, 2. toxic effects of the
drug, 3. the bacteriostatic rathE:.r than bactericidal
mechan ism o� the drug, and 4. the
some strains of streptococci.

ineff ectiveness against

-46SUSCSPTIBILII'Y OF THE ALPHA-HEIJOLYTIC ST::BPTO�;O CCUS TO
NEO;.ISPHE.1{AMil:E
Immediatel:,- ,::rior to the :introduction of penicillin,
Osgo=d (76) com::;x:,red th e effectiveness of :::eoarsphen
arnine, marph arsen, sulfanilai-nide, sulfathiazole, '-'-nd
sulfa.-n ethylthiazole upon the alpha-hemolytic strepto
cocci.

Cultures o:f human marrow were prepared, and

then a dilutio;.1. of a culture of Streptococc-...i.s virido.ns
w:.:.;.s added to about 50 cubic centimeters o:f this bone
marrovr culture vihich contained about 100,000,000 nucleated

'
mar:::.� ow cells.

A.f'ter thoroug1,. ::1ixing po'._lr Jlct.ted \Vere

made, &nd equal volumes ·;J'ere trc.:-:s:�erred to each of
2..

number of 30 cubic centimeter viu.ls.

The ..t)OUr plates

v;ere used for controls, &�.i.d the dru6 to be tested

VK-S

added to the vials and incubated at 370 Centigrade,.
and pour plates and counts were then made at regul&.r
intervals.

Accordi:ll,S to this report sulfathio.zole and

sulfametLyl thiazole as v;ell as sulfa.pyridine are all
capable of inh ibiting so�e strains of the viridans
streptococci in a concentration o= one to

io,ooo,

where

as sulfanilamide is ine=fective in this concentration.
It v12.ss also found that neoarsphe1-::.a:-1ine in a concentration
of one to 150,000 is effective a_,c:.inst more strains
thc=..n the sulfonamides, but is less effective than the
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sulfonru� ides against some strains.

It was found that

mapharsen in a concentration of one to 150,000 was

not as uniformily effective as neoarspbena'nine, or tl1e

sulfonamides.

However, although neoarsphena'Tline may

be more eJfective aga��st some strains of the StreP

tococcus viridr,ns, tLe main disadvantage is that the

concentration must be kept low enough so as not to kill the
body cells.

With these result£, in mind Osgood (75)

ouUined a form of' therapy whlch he thought would increase
the incidence of cure in cases of S\].b&cute bacterial
endocarditis .

Neoarsphenamine w as to be given to every

patient in amounts sufficient to main'tv-in a concentration
of one to 150,000 in the blood, and if on the
fourth

t..�e temperature w as still above normal,

sulf'athizaole or sulf'apy-ridine w as to be given every

f'our hours in amounts suf'f'icient to maintain a concentra
tion of 8 to 10 milligrams per 100 cubic centimeters

of' blood, and if' there had been no e::':fect upon the

temperature up to this time the neoarsphena.mine vras

to be discontinued, but if the temperature had been reduced
even the least amount the neo&.rsphenamine was
to be continued.

Thirty two cases were treated in this

manner (77), four of' which are now symptom.free.

However, penicillin was soon introduced f'ollow ing th is

-46report, and thus no other results concering the use
of neoarsphenamine were reported.

-49SUSCEPTT3ILITY OF ALPHA.-HEMOLl'"TIC STRCPTOCOCCUS TO
PElITC IIL IN
Although there have only been a few reports on

the penicillin sensitivity of the members of the alpha

hemolytic streptococci, most str<--ins isolated :from cases
of subacute bacteriL.l endocarditis huve been ·found to
be sensitive to penicillin in vitro.

The degree of

sensitivity is about the same as that shovm by the

staphylococci, but is not as grec.t as that exhibited

by the hemolytic streptococci.

This latter point

W"ciS

proven b/ an experiment in ':rh:i.ch 50 stra ins of'

nonhemolytic streptococci v1ere compL.red with a standard
strain of' u hemolytic streptococc,s. (18)

It was stated

thut the in vitro activity of' penicillin is inf'luenced by

the number of organisms prese::1t and also by the

rate of rrowth of' the organisms, and thus the cultures to

be tested were grovm for 15 hours in rabbit's blood broth
so as to produce a growth of approximately the same

density as that of a 15 1:our culture of the standard

hemolytic streptococcus.

The 50 strains were all found to

be sensitive to the ;enicillin in various degrees, but not
as sensitive as t...11e hemolytic streptococcus.

The various strains have not been classified accord
ing to their penicillin sensitivity, but it bas been
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noted that al tlioug::. the Streptococcus sul vcr ius strLl.ins
are more of'ten thought to be resistant to tr1e ection
of bacteriophages in t:1.e test tube, they are quite
sensitive to penicillin.

(61, 62)

In contrast, the

Streptococcus :fecal is, which ma�' als o be ti""1e cause o:f
subacute bacterial endocardi tis, is veriJ susceptible

to

bacter>iophages, but is relativelJ· resistant to penicillin
in vitro.

(60)

The most recent experimental \'fork which has been
done on t.i.'1e viridans streptococci indicates thi.... t in
increasing concentrations of penicillin a critical
concentration

is reached at VJ"ldch the bacteria fail to

multiply, and furth;:;r increases in the concentration
of the penicilli n cause a decrease in the numbt,r of bacteria
present. (65)

This suggests that penicillin

prod ces a bacte:�icidal as well as a bacteriostc8.tic
effect.

However, this critical concentration at which

multi::_Jlicati on is prevented vc:;,ries :for t..h.e different straim,
and tbus can be considered as a measure of' the organism's
penicillin sensitivity
.

Increases in the concentraticn

beyond this critical con centration produce an increase
in t.rie rate at which the bacteri0.

are killed, but eventually

another level o:f concentration is reached
beyond which further increases wo1..:.ld :fail to shovr any

greater bfactericidal activity.

h

This ex_;_.)L.:.ins wy the

relL-tively resistant strains o:f streptococci cannot

be killeu. Ecven b., exposing the bacteria to very high
conce�tratio�s of penicillin.

These observations

confirm t...�e reports previously m�de by Hobby, !!teyer
and Chaffee. ( 37)

It was foun::l in this same experiment

(65) that the minimal concentration of penicillin

necess""-ry to produce either a bacteriostatic or a bacteri
cidal eff0ct can be reduced 25 to 75 per cent by tJ.1e
presence of the sulfonamide drugs.

However, if' penicillin

w�s given in a concentr&tion well above that of the

sensitivity of the strain of viridans streptococci

being tested, the s-,,,:,lfoncJD.ides did not alter the rate
at which the organisms were killed.

Thus it appears

that actually the combining of one of the sulfonamides
with pen icillin does not offer any advantag es over
penicillin alone.
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TIIF�

OF PENICILLIH IN
Tl.IERAPY OF
SUBAC"U"TZ :S.ACTE TIIAL EITDOCAlIDITIS

Pe�icillin was firs-:-" used alone in the actual
treatment of patients in 1942, and the results wer•e
discouraging at first beca,:se an inadec:uate dosi.ige
was given.

Later hepu.r in was used in combim�tion with the

perdcilliL., a:1d the results were somevirmt better.
At tl::e present time the incidence of cur es with penicillin
is much higher, because massive doses are being used
over a longer period of tine.

Interest in the treatment of

subacute bacterial endocarditis w�s stL'Tlulated in
1945 ,•;hen Loev:e (58) presented evidencfc tl-:,.;;...t in his cases
the combined use of an anti-infective a.gent (pe,dcillin)
and an anticoagulant (heparin) produced an apparent
clinical cur•e in 75 per cent of his 54 patients.

Loewe

(58) also devised a new method of administering heparin,
and has thus eliminated the danger conr.ected wit h
intravenous heparin.

This method consists of the sub

cutaneous deposition of a Pitkin Menstrum wLich consists of
gelatin, dextrose, glacial acetic acid, and water.
In this manner the rate of release of water soluble
drugs which are injected is reguL.:,ted, and a more
equitable absorption of' heparin is promoted.

Loewe (58)

also conducted experiments t-o determine the effect
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'--"
of heparin on the anti-infective propert~es o~ penicillin,
and found that there w2;.s slight s-.iggestion of syngergism.

Hov,ever, the nore recent reports (30, 31) indicate
that pe"icillin may be as effective alone as ·when canbined
witL some antico0.gulant such as heparin.
'I".ne use of heparin was :first advocated in 1939
by Kelson and '.Vhite (42), and later by several other
clinicians. (27)

However us mentioned above there

have been many recent reports which inciicate thct hepc..rin
should be abandoned (19, 20, 26, 30, 31, 39, 86), and
among these are Friedman (26) and Katz (39) who pre~

viously w.dvocated the use o:f hepLrin.

Dawson (19, 20)

reports ti1&t with penicillin alone there have been
fewer emboli, and also a decreased incidence of hemorrhage.

He believes thL.t th.:. use of heparin is indicated

only ur,der tv:o conditions.

First, if t::1e cases show

large emboli lodgir..g in the major vessels, heparin may
prevent "retrograde thrombosis in the artery and t~:us
i::eep collateral circulation open 11 •

Secondly, heparin

may prevent the development of thrombophlebitis at tbe
site of the infu.sion when very lc,rge doses of' penicillin
such as 10,000,000 units per day are given.

Others

(54) advise tlie use of' heparin only in cases in v;hich

the disease fa ls to undergo remission with one course

.._,-I
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of pe:dcillin, because in this case hepc.. rin mcy
cause a disintegr;;.tion of the vegetatio:�s.

It must

also be rer.1embered thc.t there is ulwci�"s the
possibility thci t t.'1e disintegrating parts of the
vegetations rnay enter the cerebral vessels, causing
thranbosis, infarction, and death.
l�any otLer reports of cures w·ith the co:11bi1:ed use
of penicillin and hepc.rin began to appear &fter Loewe
( 58) re:1orted his Cc�ses.

Early in 1945 there was

2:.

report of' 15 cure:: out of 20 pc,..ticnts treated with
penicillin and heparin. (19)

Following this, Herrell (24)

at tb.e 1.:ayo Clinic tree.ted tw·::.: children successfully
in which the endoco.:rditis V\'a.S su perimposed -....;)on a coL
genital he&.r·t.

These cases llc:;.d 0::1:- been followed

f or two E'.Ild six months, and thu s u final evulc,tion af:.'.
to the effectiveness of the treatment cannot be made.
Between 1929 and 1944 1!lhite (97) treated 88 cases,
nine of Vfhicl1 received 1Jenicillin, the rest being givoo
sulfona::c1ides.

Of these cases there were only fou r cures,

and one of tbese had received penicillin only•

?lany

other reports of cure f'ollovdng the use of penicillin
vdth and without hep0.rin have been reported (7, 24, �l,

91), but the percentages of' cure are so varied that
no definite conc�c1sions can be dravm

c...S

to the eff'ective-
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nes s of the penicillin.

There i s a present day tenden cy to

believe tl:at penicill5.n alone can be ver-:-.1 eff'ective
in the tre�tment of' subacute bacterial endocarditis
if the organism is inhibitable by penicillin, and if
the treatment is care:f'ully outlined f'or ee,,Ch case.
There are only tvm recorded reports ir.. the literature
of' the use of dicumarol iL combination v:ith penicillin.
(67, 68)

In one of' tl1ese (68) a patient was given :f'our 100

miLdgram injections ever'J three hours
in conbinutior: with 25,000 units of intravenous penicillin
over a tvro v1eeks period.

The blood cul tureE were pos itive

f'or Streptococcus viridans before treatment wc::,s start ed,
and vrere negative af'ter t..11e tr•eatment was disccmtinued.
Eowever, there is :::o report c:.s to whether or not there
vra.s 2.ny recurrence of syrnptoms in t- is case.

In t he

other report (67) the patients were given daily dosages
of' about 1.5 milligrL.ms per kilogri,.;.m of body v,eight
·which was sufficient to maintain tLe prothrombin time
between 25 and 50 per cent of normal. This treatment vras
contir:ued for six weeks. This combined therapy gave a fairly
high percentage of cures, but, nevertheless, the □en 1AiJ.10
reported its use still do Lot believe that any type of
anticoagulant offers advantages, and ever'Jone will agree
that dicunmrol as well us heparin
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does offer certain definite disadvantages.

Seven of

the ten patients who did not recover 1-:nder tLis form
o f therapy h£..d received inc.deouate penicillin therapy
before coming- under observation, and all but on e of
t.J:1ese inadecr ;e..te

treated patien ts had shovm previous

temporary i�provement under the origin al pen icillin
therapy. This offers verJ si;.ggestive evidence "Ll�u.t the
organisms ml_:_y build

a resistance to penicillh:. if im...

dequate dosc.ges c,;.r>e given initially.

This opin ion is

agreed upon by mast of the men who hfave tr0e.ted cases of
sub-acute

bacte::·

er�docarditis.

There is also a possibility thc.t a.. elevated temp
erat::.re in combination with penicillin may be of use
in incre&s

the incidences of cures.

Studies of the

actior:. of penicillin i.� vitro have been made by Ii!assel
and his fel:ovr workers (65), ar.:d they suggest that
fc ver therapy vrith penicillit may be helpful to patients
who do r.ot respond to large and prolori..ged doses o:f peni
cillin.

In these cases the org�nisms seem to be in

hibited from multiplying, but as soon as the antibiotics
are discontinued the cultures again become ;Jositive. Thus
although the organisms in tl1 ese cases lie dormant and do
r;_ot multiply, they do remain viable.

It is

hoped that with this :forr::1 of co:wbined therapy the number
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of' these persisting organisms c&n be decreased, and
thus tre.r::.sform some of the incidences of failure into
cure.

Eov;ever, the question as to whether or not tl-:is is

:Jossi ble in the actual pc;:,tient has not as yet been
answered.

The effect of increr.sed temperature upon

penicillin is just opposite to that of ttie sulfonamides.
The lc:i.tter decrec.se the concentr2,tion of penicillin
necess1:u·.. Jfor a bacteriostasis, but do not increase th�
rate of' bacteriostasis, v.hereas an incre2,sed temperature
seeras to c.:..ccelerate the killing ratio, but does
not alter the concentratioL of the paicillin necessary to
produce a bucteriostasis.
These reporte on the use of penicillin do give
evidence that subr:cute bacterial endocu.rditis can be
cured.

EO"vrever, t}-._ere a.re many cases which are not

cured, and thus it

S:e!!B

veI"-J in:iortant to discuss these

:failures i n the hope of improving the method of peni
cillin therap:,{, ·v.rhich at the present time does definitely
give some -;-:>ope of' bein,g a cure fo:- subacute bic..cterial
endocarditis i n t�e tuture.

First of all it is

important to take strain sensitivity tests (8), because
if the organism rec1uires more tl1an one unit of peni
cillin per cubic centimeter of mtdia in order to bring
about inhibit::..an, the strain can be considered as not
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bei11..g very se::sitive, and the pu.tient will require more
th&n t�1e usual dose.

Regardless of vihat dosc:..ge is used

it must be maintained for a sufficient len gth of time
in order to permit a sterilization of the vegetations,
and thus prevent pseudo cures and recurrences.
The 0uestioL is still uru:..nswered as to how much
penicillin should be given, by v:bat route, and for how
lor-i.g a period of time.

The dosage depends upon the

sensitivi½:/ of the orgc...nism, because a ser um level
st.ould be maintained which is at least four t_:_mes as
hig'h us the amount necessary to i:ihibit the organism in
vitro. (20)

The average dose is about 250,000 units

daily, but it has been advocated th�t at le�st 500,000
units be given each d�Y. (24)
The continuous intravenous inf: sion methcc... is more
often accepted es the metr:od of administr&tion, becauS:
it enables the maintainence of a more constant level of
If' it is given intramus

penicillin in the blood.

cularly, an initial higher level is obtained, but it is
:followed by a prompt decl

so that dur ing p&.rts of

each dL-:: the blood is actually free fr om detectable
amounts of ;)enici llir..

The orid method of administra

tion h'""s only recently cone into use, and there is
little evidence at the present time

t1s

to the serum
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levels obtained in this method.

Burke and Ross (16,

82) reported the first successful treatment of subacute
bacterial e-ndocarditis with oral penicillin.

In a

preliminary report (15) they reported that with the
ingestion of a capsule containing 100;000 units of
sodium penicillin, a blood level could be obtained
w1 ich was as high or even higher than that obtained
when 40,000 units vras given parenterally.

Within 30

to 90 minutes after the oral administration there was
a rapid increase in the penicillin concentration of
the blood which was maintained at a therapeutic level
for at least three hours.

Thus they con cluded that

a therapeutic level could be maintained if 100,000
units was given orally every three hours, and if the
drug was protected from the inactivating influence of
the hydrochloric acid in the stomach.

Following this

preliminary work , Ross and Burke first used oral penicillin successfully in ' the treatment of children with
pneumonia, gonorrhea, and cellulitis. (82)

Later they

reported the successful tr~atm~nt of a case of subacute
bacterial endocarditis with oral penicillin. (16)
Aluminum hydroxide was given before each dose in order
to neutralize the aciditJ in the stomach, and the penicill:in
was placed in a double capsule wh ich provided additional
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mecha nical protect i on from the acid.

The temperature

dropped to normal, and the blood cultures became negative
within twelve hc:urs after the treatment had been started,
and remained so for eight months.

The advantages of

oral penicillin in the tre~tment of subacute ba cterial
endocarditis cun be summarized as f ollows:

(1) the

necessary dura tion of treatment is shorter, (2) the
discomfort of parenteral administra tion i s avoided,
(3) the toxic rea ctions which may occur with intravenous
injections are avoided, (4) the danger of thrombophlebitis is decrea sed because of the shorter length of
treatment, and (5) the possibility of psychic trauma
which may occur with repeated intravenous injections
is avoided.
There are n o criteria for determining the sta tus
of t he infection during therapy, and thus the length
of therapy necessary cannot be determined with certainty.
It is usually given for at least three to four weeks,
and then if' any relapses are going to occur they will
do so during the first two weeks after the penicillin
is disc ontinued.

If relapses do occur a second course

of penicillin is given using a greater dosage over a
longer period of time .

Dawson and Hunter ( 20) have

outlined a form of treatment very similar to what has
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just been described, and they believe that even though
as many as ten relpases occur, an eventual cure can still
be achieved unless complicat i ons such as cardiac failure
or embolic rhenomena develop.

They believe that with

the use of penicillin tbe causes of failures are due
to an organism which is not sensitive to penicillin.
It must also be remembered that penicillin itself
may produce anatomic changes on the valves on which
veget~t i ons are present, and thus result in the development of cardiac failure.

This possibility is supported

by an autopsy (8) of a treated case with mitral stenosis
in which the valves were healed, but reduced to small
shrunken vestiges after the vegetations had been absorbed.

This indicates that

pa1

icillin therapy must

be sta :~ted before t he valves are extremely affected
in order to avoid the development of heart failure.
And if this is done penicillin may be able to hasten
the natural tendency to healing, and thus make clinical
recovery possible.
have

11

Loewe (58) states that patients

the optimum chance for cure", if they are seen

soon after the onset of the bacteremia, have relatively
small vegetations, do not suffer :f'rom cardiac failure,
and are infected by a penicillin sensitive organism.
If the patient has apparently recovered it is
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generally advised that he have a careful physical checkup at least once a month for the first year with special
attention being placed upon the possible f'oci of' infection.
Diseas€d tonsils or absessed teeth shruld always be
removed, however, this type of' surgery should be pre,ceded
and followed by penicillin, because even minor manipulations of' the teeth and gums may give rise to a
bacteremia. (12, 54)

Okell and Elliot (73) ~intain

that following dental extractions 75 percent of' the
patients with septic mruths, and 34 percent of the
patients without any obvious dental infections will
develop a bacteremia..

Thus tl1e importance of giving

penicillin prior to dental surgery to patients who
already have damaged hea rt valves cannot be overstressed.
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THE USE OF STREPTCMYCIN IN THE THERAPY OF
SUBACUTE BACTERIAL ENOOCARDITIS

The latest drug to be used in the trea tment of
subacut·e bacterial endocarditis is streptomycin.

Although

few reports concerning its use have been reported as
yet, it has been shovm to inhibit the grovrth of the
influenza bacillus and other gram-negative bacteria.
(40)

Thus streptomycin would appear to be the drug

of ch oice in treating the rare cases of subacute b&cterial endocarditis caused by gram-negative bacteria. '
Some of the · strains of the Streptococc1.:-. s viridans
organisms which a re qu ite insensitive to penicillin
have been found to be relatively sensitive to streptomycin even though the organisms are gram-positive.
Priest and McGee (80) very recently reported the use
of streptomycin in three cases of subacute bacterial
endocarditis ., caused by -the Streptococcus viridans,
which were insensitive to penicillin .

The growth of

the organisms in vitro was inhibited by a concentration
of from

.s

to 60 units per cubic centimeter of penicillin,

whereas the organisms were inhibit ed by a concentration
of .1 to 1 unit per cubic cen timeter of streptomycin.
In the first cas e the streptomycin produced a sterilization of the valwlar lesions after penicillin had
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proven to be of no ava il, but the stre ptomycin w~s
given too l ~te i n the course of tbe dise&se to a ffect
a cure.
after

c.

In the second ca se negative cultures resulted
course of' streptontlcin trea tment bad been given,

however, the supply of strep1,omycin wa s exhausted after
eleven d~ys, and penicillin was subs tituted.

Thus although

.

the patient wa s cur ed it remains a question as to whether
or not the penicillin, which was given following the
stre ptomycin, had any part in bringing about tbe cure.
In the third ca se streptomycin alone wa s g iven after
penicillin had f &iled, and the blood was negative in
48 hours, and had remained negative for eight months
at the time of the re port.

In these three case s 500,000

units of streptomycin was given daily by interru~ted
intermuscular injections over a period of three weeks
in an attempt to maint&in the serum level of streptomycin a t three to twelve units per cubic centimeter.
Thus it appears that in the futur e streptomycin may
be ver'-J effective in treating tbose cass s of subacute
bacterial endocarditis in which the etiological organisms
_a re resistant to penicillin.
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SUlviIJARY Al\Jl ) CONCLUSI01'S

As has been pointed out there

2...

re many strains

o:f the _a lpha-hemolytic s tre ptoc oc cus, and it is only
the non-hemolytic "green-producing" strc..ins better
knovm a s Streptococcus viridans which are o:f importance
in the etiolog,J 6:f subacute bacterial endocarditis.
However, the virid~ns organisms are composed o:f various
species, which ca n be di:f:ferentiated according to their
bacteriological char acteristics; and according to the
most recent clas s ificati on only two (Streptococcus
s alvarius and Streptococcus equ inis) o:f the :five organisms
cla ssed as viridans org~nisms can be considered a s
possible cause s o:f subacute bacterial endocarditis.
The Streptococcus :fecalis, which as yet has not definitely
been recognized as a member o:f t he alpha-hemolytic
group , is also a cause o:f subacute bacterial endocarditis
in some ca ses.

A new variety o:f streptococci, which

has been given the name Streptococcus s.b.e., has very
recently been isolated :from this type o:f endocarditis,
and has also been proposed as a new member o:f the virid~ns
group b ecause o:f their similar characteristics .

Thus

future studies a re required before any definite classification can be made .
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In view of the work wh ich has been investigated
it car: be concluded that the sulfonamides are quite
ineffective aga inst the alpha-hemolytic streptococci,
and are t hus of little value in the t r ea.t.'Ilent of suba cute ba cterial endocarditis.

However, with the advent

of penicillin the incidence of cures has increc.sed, aLd
there is definite proof that m~ny of the strains of
the a lpha-hemolytic streptococci are susceptible .to
penicillin , but their deg ree of susc ept ibility ,-var ies
with the different str&ins.

Thus it is very im~ortc..nt

to test the sensitivity of the organisms bet·ore adminis-

tering penicillin to the patient, and if this is done
the incidence of cures is very like l y to be incre~sed.
Up to the present time penicillin hus been more
eff ective against more strains of the Streptococcus
viridans than any other drug .

Streptomycin has proven

to be effective in tre&ting thos e r ~re cus es of endocarditis due to gr~m-negative organisms , ·anc. hc.. s also
been e ffe ctive at:t-inst some stra ins of the Streptococcus
viridans which are re sistant to penicillin.

And because

of this fact, it would be very interesting to determine
the effect of streptomycin aga i nst the Stre pt oc occus s.b.e.,
which apparently is not ai~eptib>le to penic i ll.in.

It

is very possible tha t this new organism is the st~epto-
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cuccous which has been found to be resistant to penicillin, but
susceptible to streptomycin. In summary it can be said that the outlook
for patients suffering from subacute bacterial endocarditis is much
brighter than it was 10 years ago; and with the continued use of
penicillin, and the promising future use of streptomycine for those
strains which do not respond to penicillin, there is very likely to be an
even greater .increase in the incidence of cure in this disease. However,
although the prognosis has greatly increased during the past 10 years
the treatment of subacute bacterial endocarditis is still a challenge to the
medical world just as it has been since it was first clinically recognized.
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